Buy ADVAIR HFA 45 ug/1 fluticasone propionate and salmeterol xinafoate

ADVAIR HFA 45 ug/1 is a combination inhaler containing fluticasone propionate and salmeterol xinafoate. It is designed for respiratory use and is commonly used for managing asthma and chronic obstructive pulmonary disease (COPD). This metered aerosol inhaler is manufactured by GlaxoSmithKline LLC.

Strength

45 ug/1

Pack Size

1 INHALER in 1 CARTON (0173-0715-22) / 60 AEROSOL, METERED in 1 INHALER

Manufacturer / TM Owner

GlaxoSmithKline LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

ADVAIR HFA 45 ug/1 is primarily used for the maintenance treatment of asthma and to prevent bronchospasm in patients with COPD. The combination of fluticasone propionate, a corticosteroid, and salmeterol xinafoate, a long-acting beta-agonist, works to reduce inflammation and relax the muscles in the airways. This inhaler is often prescribed for individuals who require both types of medication to manage their respiratory conditions effectively.

Side Effects

Common effects of using ADVAIR HFA 45 ug/1 may include a reduction in asthma symptoms such as wheezing, shortness of breath, and coughing. Some users may experience mild side effects like throat irritation, hoarseness, or a dry mouth. It is important to use the inhaler as directed by a healthcare professional to minimize potential side effects.

Precautions & Warnings

ADVAIR HFA 45 ug/1 should be used with caution, especially in individuals with a history of severe asthma attacks or those who are allergic to any of its components. It is important to follow the prescribed dosage and administration instructions to avoid overuse. Regular monitoring by a healthcare professional is recommended to ensure the medication is working effectively and to manage any potential side effects.

Avoid Interactions

ADVAIR HFA 45 ug/1 may interact with other medications, including beta-blockers, diuretics, and certain antibiotics. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, the use of alcohol or other respiratory depressants should be discussed with a healthcare professional to ensure safe and effective use of the inhaler.

References

Frequently Asked Questions

ADVAIR HFA 45 ug/1 is used for the maintenance treatment of asthma and to prevent bronchospasm in patients with COPD.

ADVAIR HFA 45 ug/1 should be administered by inhalation, following the instructions provided by your healthcare professional.

Common side effects may include throat irritation, hoarseness, and dry mouth. Always consult a healthcare professional for personalized advice.

ADVAIR HFA 45 ug/1 may interact with other medications, so it is important to discuss all your medications with a healthcare professional.

Long-term use of ADVAIR HFA 45 ug/1 should be monitored by a healthcare professional to ensure its continued safety and effectiveness.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.